These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33671944)

  • 1. Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection.
    Korematsu T; Koga H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?
    Cabrera-Rubio R; Calvo C; Alcolea S; Bergia M; Atucha J; Pozo F; Casas I; Arroyas M; Collado MC; García-García ML
    Microbiol Spectr; 2024 Jul; 12(7):e0255623. PubMed ID: 38785596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.
    de Steenhuijsen Piters WA; Heinonen S; Hasrat R; Bunsow E; Smith B; Suarez-Arrabal MC; Chaussabel D; Cohen DM; Sanders EA; Ramilo O; Bogaert D; Mejias A
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1104-1115. PubMed ID: 27135599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis.
    Zhang X; Zhang X; Zhang N; Wang X; Sun L; Chen N; Zhao S; He Q
    Pediatr Allergy Immunol; 2020 Apr; 31(3):281-289. PubMed ID: 31788862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses.
    Ederveen THA; Ferwerda G; Ahout IM; Vissers M; de Groot R; Boekhorst J; Timmerman HM; Huynen MA; van Hijum SAFT; de Jonge MI
    Microbiome; 2018 Jan; 6(1):10. PubMed ID: 29325581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.
    Diaz-Diaz A; Bunsow E; Garcia-Maurino C; Moore-Clingenpeel M; Naples J; Juergensen A; Mertz S; Wang H; Leber AL; Gern J; Hall MW; Cohen DM; Ramilo O; Mejias A
    J Infect Dis; 2022 Mar; 225(5):912-923. PubMed ID: 34543409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial.
    Man WH; Scheltema NM; Clerc M; van Houten MA; Nibbelke EE; Achten NB; Arp K; Sanders EAM; Bont LJ; Bogaert D
    Lancet Respir Med; 2020 Oct; 8(10):1022-1031. PubMed ID: 32203712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae colonization of the nasopharynx is associated with increased severity during respiratory syncytial virus infection in young children.
    Brealey JC; Chappell KJ; Galbraith S; Fantino E; Gaydon J; Tozer S; Young PR; Holt PG; Sly PD
    Respirology; 2018 Feb; 23(2):220-227. PubMed ID: 28913912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome-Transcriptome Interactions Related to Severity of Respiratory Syncytial Virus Infection.
    Sonawane AR; Tian L; Chu CY; Qiu X; Wang L; Holden-Wiltse J; Grier A; Gill SR; Caserta MT; Falsey AR; Topham DJ; Walsh EE; Mariani TJ; Weiss ST; Silverman EK; Glass K; Liu YY
    Sci Rep; 2019 Sep; 9(1):13824. PubMed ID: 31554845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity.
    Harding JN; Siefker D; Vu L; You D; DeVincenzo J; Pierre JF; Cormier SA
    BMC Microbiol; 2020 Jun; 20(1):140. PubMed ID: 32487019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial colonization dynamics associated with respiratory syncytial virus during early childhood.
    Brealey JC; Young PR; Sloots TP; Ware RS; Lambert SB; Sly PD; Grimwood K; Chappell KJ
    Pediatr Pulmonol; 2020 May; 55(5):1237-1245. PubMed ID: 32176838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus--viral biology and the host response.
    Hacking D; Hull J
    J Infect; 2002 Jul; 45(1):18-24. PubMed ID: 12217726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review.
    Yagi K; Lukacs NW; Huffnagle GB; Kato H; Asai N
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway Gene Expression Correlates of Respiratory Syncytial Virus Disease Severity and Microbiome Composition in Infants.
    Chu CY; Qiu X; McCall MN; Wang L; Corbett A; Holden-Wiltse J; Slaunwhite C; Grier A; Gill SR; Pryhuber GS; Falsey AR; Topham DJ; Caserta MT; Walsh EE; Mariani TJ
    J Infect Dis; 2021 May; 223(9):1639-1649. PubMed ID: 32926149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection.
    Resch B; Gusenleitner W; Mueller WD
    Acta Paediatr; 2007 Apr; 96(4):495-8. PubMed ID: 17326757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal bacterial burden and antibiotics: Influence on inflammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis.
    Suárez-Arrabal MC; Mella C; Lopez SM; Brown NV; Hall MW; Hammond S; Shiels W; Groner J; Marcon M; Ramilo O; Mejias A
    J Infect; 2015 Oct; 71(4):458-69. PubMed ID: 26149186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients.
    Hishiki H; Ishiwada N; Fukasawa C; Abe K; Hoshino T; Aizawa J; Ishikawa N; Kohno Y
    J Infect Chemother; 2011 Feb; 17(1):87-90. PubMed ID: 20700753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis.
    Mansbach JM; Hasegawa K; Piedra PA; Avadhanula V; Petrosino JF; Sullivan AF; Espinola JA; Camargo CA
    J Infect Dis; 2019 May; 219(11):1804-1808. PubMed ID: 30590603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease.
    Wang EE; Law BJ; Robinson JL; Dobson S; al Jumaah S; Stephens D; Boucher FD; McDonald J; Mitchell I; MacDonald NE
    Pediatrics; 1997 Mar; 99(3):E9. PubMed ID: 9099774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
    O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M;
    Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.